Nakagawa T, Wakamatsu K, Zhang N, Maeda S, Minami M, Satoh M, Kaneko S
Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Neuroscience. 2007 Jun 29;147(2):445-55. doi: 10.1016/j.neuroscience.2007.03.045. Epub 2007 Jun 1.
Several lines of evidence suggest that extracellular ATP plays a role in pain signaling through the activation of ionotropic P2X-receptors, especially homomeric P2X3- and heteromeric P2X2/3-receptors on capsaicin-sensitive and -insensitive primary afferent neurons, respectively, at peripheral and spinal sites. We investigated the mechanisms of the induction and maintenance of mechanical allodynia produced by a single intrathecal (i.t.) administration of ATP in rats. We found that i.t. administration of ATP and the P2X-receptor agonist alpha,beta-methylene-ATP produced tactile allodynia which lasted more than 1 week. The i.t. ATP- and alpha,beta-methylene-ATP-produced long-lasting allodynia remained in neonatal capsaicin-treated adult rats. I.t. administration of a P2X3/P2X2/3-receptor selective antagonist completely prevented the induction (co-administration on day 0) and partially attenuated the early phase (day 1 post-ATP administration), but not the late phase (day 7 post-ATP administration) of maintenance of allodynia. The N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 completely prevented the induction phase, but not the early and late phases of maintenance of allodynia. Immunohistochemical and immunoblotting studies for microglial and astrocytic markers revealed that i.t. ATP administration caused spinal microglial activation within 1 day, and astrocytic activation which peaked at 1-3 days after ATP administration. Furthermore, minocycline, a microglial inhibitor, attenuated the induction but not the early and late phases of maintenance, while fluorocitrate, a glial metabolic inhibitor, attenuated the induction and the early phase but not the late phase of maintenance. Taken together, these results suggest that the activation of P2X-receptors, most likely spinal P2X2/3-receptors on capsaicin-insensitive primary afferent neurons, triggers the induction of long-lasting allodynia through NMDA receptors, and the induction and early maintenance phase, but not the late phase, is mediated through the functions of spinal glial cells.
多条证据表明,细胞外ATP通过激活离子型P2X受体在疼痛信号传导中发挥作用,特别是分别作用于外周和脊髓部位对辣椒素敏感和不敏感的初级传入神经元上的同聚体P2X3受体和异聚体P2X2/3受体。我们研究了大鼠鞘内单次注射ATP产生机械性异常性疼痛的诱导和维持机制。我们发现,鞘内注射ATP和P2X受体激动剂α,β-亚甲基ATP会产生持续超过1周的触觉异常性疼痛。鞘内注射ATP和α,β-亚甲基ATP产生的长期异常性疼痛在新生期经辣椒素处理的成年大鼠中依然存在。鞘内注射P2X3/P2X2/3受体选择性拮抗剂可完全阻止异常性疼痛的诱导(第0天联合给药),并部分减轻维持期的早期阶段(ATP给药后第1天),但不能减轻维持期的晚期阶段(ATP给药后第7天)。N-甲基-D-天冬氨酸(NMDA)受体拮抗剂MK-801可完全阻止诱导期,但不能阻止异常性疼痛维持期的早期和晚期阶段。对小胶质细胞和星形胶质细胞标志物的免疫组织化学和免疫印迹研究表明,鞘内注射ATP在1天内引起脊髓小胶质细胞活化,并在ATP给药后1 - 3天达到峰值的星形胶质细胞活化。此外,小胶质细胞抑制剂米诺环素可减轻诱导期,但不能减轻维持期的早期和晚期阶段,而胶质细胞代谢抑制剂氟柠檬酸可减轻诱导期和早期阶段,但不能减轻维持期的晚期阶段。综上所述,这些结果表明,P2X受体的激活,最有可能是辣椒素不敏感的初级传入神经元上的脊髓P2X2/3受体,通过NMDA受体触发长期异常性疼痛的诱导,并且诱导和早期维持阶段,但不是晚期阶段,是通过脊髓胶质细胞的功能介导的。